These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6716376)

  • 1. Towards new vaccines.
    Young CR
    J R Soc Med; 1984 Apr; 77(4):261-3. PubMed ID: 6716376
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
    Brown F
    Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
    [No Abstract]   [Full Text] [Related]  

  • 3. Selecting candidate antigens for malaria vaccines.
    Kidson C; Saul A; Schofield L; Upcroft J; Don M; Read D; Myler P; Castelino D; Chiu S; Ingram L
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):325-8. PubMed ID: 6085274
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.
    Ballou WR; Rothbard J; Wirtz RA; Gordon DM; Williams JS; Gore RW; Schneider I; Hollingdale MR; Beaudoin RL; Maloy WL
    Science; 1985 May; 228(4702):996-9. PubMed ID: 2988126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for a malaria sporozoite vaccine.
    Lancet; 1983 Jun; 1(8338):1368-9. PubMed ID: 6134142
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccinia virus: an expression vector for genes from parasites.
    Smith GL; Cheng KC; Moss B
    Parasitology; 1986; 92 Suppl():S109-17. PubMed ID: 3520448
    [No Abstract]   [Full Text] [Related]  

  • 7. A synthetic peptide which elicits neutralizing antibody against human rhinovirus type 2.
    Francis MJ; Hastings GZ; Sangar DV; Clark RP; Syred A; Clarke BE; Rowlands DJ; Brown F
    J Gen Virol; 1987 Oct; 68 ( Pt 10)():2687-91. PubMed ID: 2822846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New advances in animal and human virus vaccines.
    Rowlands DJ
    Adv Biotechnol Processes; 1986; 6():253-85. PubMed ID: 3535833
    [No Abstract]   [Full Text] [Related]  

  • 9. In search of novel immunogens.
    Newmark P
    Nature; 1984 Oct 11-17; 311(5986):510-1. PubMed ID: 6207436
    [No Abstract]   [Full Text] [Related]  

  • 10. The iscom antigen-presenting system.
    Morein B
    Nature; 1988 Mar; 332(6161):287-8. PubMed ID: 3347272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic vaccines: present and future.
    Arnon R; Sela M
    Ann Inst Pasteur Immunol (1985); 1985; 136D(3):271-82. PubMed ID: 3913380
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of synthetic peptides in virology].
    Truyen U; Kaaden OR
    Dtsch Tierarztl Wochenschr; 1989 Feb; 96(2):69-72. PubMed ID: 2647457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mimicking foot-and-mouth disease virus antigens with synthetic peptides.
    Rowlands DJ
    Ann Sclavo Collana Monogr; 1984; 1(2):147-61. PubMed ID: 6100728
    [No Abstract]   [Full Text] [Related]  

  • 14. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope specific immunity elicited by totally synthetic monovalent or polyvalent vaccines.
    Chedid L; Audibert F; Jolivet M; Carelli C; Uzan M; Gras-Masse H; Tarter A
    Ann Sclavo Collana Monogr; 1984; 1(2):77-85. PubMed ID: 6400358
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic peptide vaccine for hepatitis B.
    Hollinger FB; Dreesman GR; Sparrow J; Melnick JL
    Dev Biol Stand; 1983; 54():113-6. PubMed ID: 6228451
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent trends in veterinary vaccines.
    Bittle JL
    Prog Clin Biol Res; 1985; 178():621-6. PubMed ID: 4011619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asexual blood stage vaccines: from merozoites to peptides.
    Perrin LH; Simitsek P; Fasani-Ghersa P
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():53-6. PubMed ID: 2696161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of the branched multiple antigenic peptide system in the development of vaccine].
    Liu XY; Zhang ZQ
    Bing Du Xue Bao; 2011 Jan; 27(1):86-90. PubMed ID: 21462513
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of 2-alkoxy-8-hydroxyadenylpeptides: towards synthetic epitope-based vaccines.
    Weterings JJ; Khan S; van der Heden GJ; Drijfhout JW; Melief CJ; Overkleeft HS; van der Burg SH; Ossendorp F; van der Marel GA; Filippov DV
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3258-61. PubMed ID: 16581248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.